Abstract
Computational models of human glucose homeostasis can provide insight into the physiological processes underlying the observed inter-individual variability in glucose regulation. Modelling approaches ranging from "bottom-up" mechanistic models to "top-down" data-driven techniques have been applied to untangle the complex interactions underlying progressive disturbances in glucose homeostasis. While both approaches offer distinct benefits, a combined approach taking the best of both worlds has yet to be explored. Here, we propose a sequential combination of a mechanistic and a data-driven modeling approach to quantify individuals' glucose and insulin responses to an oral glucose tolerance test, using cross sectional data from 2968 individuals from a large observational prospective population-based cohort, the Maastricht Study. The best predictive performance, measured by R2 and mean squared error of prediction, was achieved with personalized mechanistic models alone. The addition of a data-driven model did not improve predictive performance. The personalized mechanistic models consistently outperformed the data-driven and the combined model approaches, demonstrating the strength and suitability of bottom-up mechanistic models in describing the dynamic glucose and insulin response to oral glucose tolerance tests.
Copyright: © 2023 Erdős et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Blood Glucose*
-
Cross-Sectional Studies
-
Glucose*
-
Humans
-
Insulin
-
Prospective Studies
Substances
-
Glucose
-
Blood Glucose
-
Insulin
Grants and funding
This study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041), Stichting De Weijerhorst (Maastricht, The Netherlands), the Pearl String Initiative Diabetes (Amsterdam, The Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), CARIM School for Cardiovascular Diseases (Maastricht, The Netherlands), CAPHRI Care and Public Health Research Institute (Maastricht, The Netherlands), NUTRIM School for Nutrition and Translational Research in Metabolism (Maastricht, the Netherlands), Stichting Annadal (Maastricht, The Netherlands), Health Foundation Limburg (Maastricht, The Netherlands), and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, The Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands), and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). In addition, the project was executed under the auspices of TiFN, a public - private partnership on precompetitive research in food and nutrition (grant 16NH04 obtained by E.E.B, M.E.A, I.C.W.A and N.vR.) with support from DSM Nutritional Products, FrieslandCampina (Amersfoort, The Netherlands), Danone Nutricia Research (Utrecht, The Netherlands) and the Topsector Agri & Food (Wageningen, The Netherlands). Additional funding by the Netherlands Organisation for Scientific Research (NWO; grant ALWTF.2016.021) was awarded to I.C.W.A and N.vR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.